HIV-1-infected patients with advanced disease failing a raltegravir-containing salvage regimen in São Paulo, Brazil

International Journal of Antimicrobial Agents
Jaqueline de Souza CavalcantiSão Paulo Salvage Workgroup

Abstract

Raltegravir (RAL) is the first licensed antiretroviral integrase inhibitor that may be used both for treatment-naïve human immunodeficiency virus type 1 (HIV-1) patients and for salvage therapy. The Brazilian public free access programme limits its use for salvage therapy, with scarce information regarding RAL resistance from patients failing a RAL-containing salvage regimen. This study evaluated RAL resistance mutations detected by population sequencing in 69 HIV-infected patients with advanced disease failing a RAL-containing regimen in a real-world setting. RAL resistance mutations were identified in 47/69 patients (68%). The most common salvage regimen, used by 56/69 patients (81%), included lamivudine, tenofovir, darunavir/ritonavir and RAL. At failure, major RAL resistance mutations included Q148H/R/K (21/47; 45%), N155H (14/47; 30%), Y143R/H/C (3/47; 6%) and E92Q (1/47; 2%). Most samples with Q148H/R/K also showed G140S/A/C (21/47; 45%). RAL resistance was significantly associated with less than two active drugs in the optimised background therapy regimen at failure [39/39 (100%) vs. 9/17 (53%); P<0.001] and with a longer cumulative duration with detectable viraemia (viral load >50 copies/mL) (86 weeks vs. 32 weeks; P=0....Continue Reading

References

Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·A S EspesethD J Hazuda
Jul 25, 2008·The New England Journal of Medicine·Roy T SteigbigelUNKNOWN BENCHMRK Study Teams
Aug 19, 2008·Journal of Virological Methods·Kristel Van LaethemAnne-Mieke Vandamme
Dec 1, 2010·Antimicrobial Agents and Chemotherapy·Masanori KobayashiTamio Fujiwara
Jun 23, 2011·Infection and Drug Resistance·Jean L MbisaPatricia A Cane
May 9, 2012·Antiviral Research·Jaqueline Souza CavalcantiLuís Fernando de Macedo Brígido
Jan 9, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·José Ernesto VidalAdrián Vladimir Hernández
Apr 9, 2013·International Journal of Antimicrobial Agents·Anne-Geneviève MarcelinUNKNOWN ANRS AC11 Resistance Group

❮ Previous
Next ❯

Citations

Nov 12, 2014·The Journal of Antimicrobial Chemotherapy·Jaqueline de Souza CavalcantiLuis Fernando de Macedo Brigido

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

The New England Journal of Medicine
Roy T SteigbigelBENCHMRK Study Teams
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
Daria Hazuda
© 2021 Meta ULC. All rights reserved